Lomond Therapeutics creates pharmacological platforms that target escape mutations.
Lomond Therapeutics has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Lomond Therapeutics's investors include OrbiMed, Deerfield Management, Qatar Investment Authority, American Financial Group, Torrey Pines Investment.
Lomond Therapeutics is headquartered in San Diego, United States.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
Lomond Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lomond Therapeutics — Funding & Investors." VCBacked, March 27, 2025, https://www.vcbacked.co/company/lomond-therapeutics. Accessed August 4, 2026.
VCBacked. (2025). Lomond Therapeutics — Funding & Investors. Retrieved August 4, 2026, from https://www.vcbacked.co/company/lomond-therapeutics
{{cite web |title=Lomond Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lomond-therapeutics |website=VCBacked |access-date=August 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated